Literature DB >> 3597366

Kyotorphin (tyrosine-arginine) synthetase in rat brain synaptosomes.

H Ueda, Y Yoshihara, N Fukushima, H Shiomi, A Nakamura, H Takagi.   

Abstract

Kyotorphin (Tyr-Arg) is a unique neuropeptide which produces analgesia by releasing Met-enkephalin from slices of the brain and spinal cord. Recent studies revealed that kyotorphin possesses the properties of neurotransmitter/neuroregulator. In the present study, we identified a kyotorphin synthetase in the soluble fraction of rat brain synaptosomes (synaptosol) and characterized it. The enzyme partially purified with Sephacryl S-300 showed an absolute requirement for ATP, MgCl2, tyrosine, and arginine. The optimal pH was 7.5-9.0 and the pI was determined to be 6.1-6.2 by isoelectric focusing. The Km was 25.6 microM for tyrosine, 926 microM for arginine, 294 microM for ATP, and 442 microM for MgCl2. The Vmax was 34.0 pmol/mg of protein/h. The apparent molecular size of this "kyotorphin synthetase" further purified by the DE52 column was 240,000-245,000 daltons, estimated using TSKgel G4000SW column chromatography. The enzyme reaction is represented by the following equation: Tyr + Arg + ATP + MgCl2 + kyotorphin synthetase----Tyr-Arg (kyotorphin) + AMP + PPi + MgCl2 + kyotorphin synthetase. The regional distribution and subcellular localization of the synthetase showed a close correlation to that of kyotorphin levels in the rat brain. The amounts of kyotorphin formed from amino acids by the synthetase in the dialyzed synaptosol was 3.0-4.0 times higher than that from precursor proteins by processing enzymes within the 30 min incubation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3597366

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Dipeptidase activities in rat brain synaptosomes can be distinguished on the basis of inhibition by bestatin and amastatin: identification of a kyotorphin (Tyr-Arg)-degrading enzyme.

Authors:  A T Orawski; W H Simmons
Journal:  Neurochem Res       Date:  1992-08       Impact factor: 3.996

2.  The pH-dependent conformational states of kyotorphin: a constant-pH molecular dynamics study.

Authors:  Miguel Machuqueiro; António M Baptista
Journal:  Biophys J       Date:  2006-12-15       Impact factor: 4.033

3.  Coordinated transcriptional regulation of the unc-25 glutamic acid decarboxylase and the unc-47 GABA vesicular transporter by the Caenorhabditis elegans UNC-30 homeodomain protein.

Authors:  C Eastman; H R Horvitz; Y Jin
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

4.  ywfE in Bacillus subtilis codes for a novel enzyme, L-amino acid ligase.

Authors:  Kazuhiko Tabata; Hajime Ikeda; Shin-Ichi Hashimoto
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

5.  Enhanced antinociceptive response to intracerebroventricular kyotorphin in Pept2 null mice.

Authors:  Huidi Jiang; Yongjun Hu; Richard F Keep; David E Smith
Journal:  J Neurochem       Date:  2009-04-04       Impact factor: 5.372

6.  Comparison of antinociception induced by supraspinally administered L-arginine and kyotorphin.

Authors:  A Kawabata; S Manabe; H Takagi
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

7.  L-arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway.

Authors:  A Kawabata; N Umeda; H Takagi
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

8.  L-leucyl-L-arginine, naltrindole and D-arginine block antinociception elicited by L-arginine in mice with carrageenin-induced hyperalgesia.

Authors:  A Kawabata; Y Nishimura; H Takagi
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

9.  Amino acids that centrally influence blood pressure and regional blood flow in conscious rats.

Authors:  Yumi Takemoto
Journal:  J Amino Acids       Date:  2012-05-29

Review 10.  Pharmacological Potential of the Endogenous Dipeptide Kyotorphin and Selected Derivatives.

Authors:  Juliana Perazzo; Miguel A R B Castanho; Sónia Sá Santos
Journal:  Front Pharmacol       Date:  2017-01-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.